• DOI:10.1517/14656566.7.17.2341
Corpus ID: 2587029

New pharmacological approaches for the treatment of alcoholism

@article{Soyka2006NewPA,
  title={New pharmacological approaches for the treatment of alcoholism},
  author={M. Soyka and S. R{\"o}sner},
  journal={Expert Opinion on Pharmacotherapy},
  year={2006},
  volume={7},
  pages={2341 - 2353}
}

M. Soyka, S. Rösner

Published 2006

Medicine

Expert Opinion on Pharmacotherapy

Pharmacological relapse prevention in alcoholism is a rather new clinical field with few drugs being available. Acamprosate, acting predominantly via glutamatergic pathways, and the opioid receptor antagonist naltrexone, were both shown to be efficient in improving rates for continuous abstinence, and not relapsing to heavy drinking in a number of clinical trials and meta-analyses. There are conflicting data on both drugs, especially for acamprosate, according to some recent US studies. However… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed